DEFA14A: Monogram Urges Shareholder Vote on Zimmer Biomet Merger

Monogram Technologies Inc. is reminding shareholders to vote on the proposed acquisition by Zimmer Biomet Holdings, Inc. and offering guidance on share transfers.

Summary

• Shareholders have an opportunity to move their shares from Monogram Technologies Inc. to their brokerage firm to streamline payment of the applicable merger consideration upon consummation of Zimmer Biomet Holdings, Inc.'s proposed acquisition or to trade shares prior to consummation.
• Instructions are provided for paying DRS transfer fees directly through my.equitystock.com and for generating DRS statements if fees are paid or not applicable, enabling transfer to a brokerage firm.
• A special meeting of shareholders is scheduled for September 30, 2025, where shareholders will vote on the company's proposals.
• The Board of Directors unanimously recommends that shareholders vote FOR the Merger and related proposals.
• Shareholders are urged to cast their vote immediately, as not voting will have the same effect as voting against the Merger.

Sentiment

Score: 7

Explanation: The filing reflects a positive sentiment towards the proposed merger, as evidenced by the Board's unanimous recommendation and the strong encouragement for shareholders to vote 'FOR' the transaction. It is a procedural step to finalize a strategic acquisition.

Positives

• The Board of Directors unanimously recommends voting FOR the Merger, indicating strong internal support and confidence in the transaction.
• Shareholders are provided with clear guidance and options to manage their shares, either to facilitate merger consideration payment or to trade shares before the acquisition is finalized.

Negatives

• The explicit warning that 'not voting will have the same effect as voting against the Merger' suggests a potential concern regarding shareholder apathy or opposition that could jeopardize the merger's approval.
• The mention of DRS transfer fees implies a potential administrative hurdle or cost for some shareholders wishing to transfer their shares.

Risks

• The proposed acquisition by Zimmer Biomet Holdings, Inc. is contingent upon shareholder approval, posing a risk that the merger may not be consummated if the required votes are not secured.
• Shareholder inaction, specifically failing to cast a vote, carries the same consequence as voting against the Merger, which could inadvertently lead to the transaction's failure.

Future Outlook

The company anticipates the consummation of the proposed acquisition by Zimmer Biomet Holdings, Inc., contingent upon shareholder approval at the upcoming special meeting.

Management Comments

• "Your Board of Directors unanimously recommends that you vote FOR the Merger and related proposals."
• "Monogram urges you to cast your vote TODAY."
• "Remember, not voting will have the same effect as voting against the Merger."

Industry Context

This communication represents a standard procedural step in the process of a publicly traded company being acquired, reflecting ongoing consolidation activities within the broader industry. It focuses on shareholder engagement necessary to finalize a strategic acquisition.

Stakeholder Impact

• Shareholders: Will receive merger consideration upon consummation of the acquisition and are required to vote on the merger proposals.
• Monogram Technologies Inc.: Is in the process of being acquired by Zimmer Biomet Holdings, Inc., which will result in a change of ownership and operational structure.

Next Steps

• Shareholders are required to vote on the proposed merger and related proposals at the special meeting on September 30, 2025.
• Upon shareholder approval, the proposed acquisition of Monogram Technologies Inc. by Zimmer Biomet Holdings, Inc. is expected to be consummated.

Key Dates

Recommendation

The company is in the process of being acquired, and its stock price is likely to be closely tied to the proposed merger consideration. A 'hold' recommendation is appropriate as investors should either await the merger's completion to receive consideration or consider trading their shares based on the current market price relative to the merger terms. The primary decision for shareholders is to vote on the merger.

Keywords

Monogram Technologies, Zimmer Biomet, Merger, Acquisition, Proxy Statement, Shareholder Vote, DRS Transfer, Corporate Governance